BOXER CAPITAL LLC
Q1 2022 Form 13-F
SAN DIEGO, CALIFORNIA
CIK 0001465837
· CRD 330106
· SEC-registered investment adviser
$1.9B Reported Value Total
Private funds (Form ADV)
2 funds
· $578.2M gross asset value
Hedge Fund: $578.2M
Source: Form ADV filed 2026-05-11
Reported value
$1.9B
Quarter over quarter
-26.4%
Holdings
74
Top-10 concentration
47.9%
Filing Structure
Reports holdings for
- Aviva Holdings Ltd. (not a 13F filer in our records) · File #28-17342 · Q1 2016 – Q3 2017 · declared by one filing
- Aviva Holdings Ltd. (not a 13F filer in our records) · Q4 2015 – Q4 2015 · declared by one filing
Key People
Form ADV owners & control persons
LLC Boxer Holdings Gp
MANAGER
Aaron Isaac Davis
MANAGER AND MEMBER
Tiffany Ann Ayres
CHIEF COMPLIANCE OFFICER AND LEGAL COUNSEL
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2022 13F record
Q1 2022 13F filing summary
| Period of report | March 31, 2022 |
|---|---|
| Filed | May 16, 2022 |
| Form | 13F-HR |
| Reported value | $1.9B |
| Positions | 74 |
| Change in reported value | -24.4% |
| New positions | 8 |
| Exited positions | 4 |
| Position turnover | 15.4% |
| Top-10 concentration | 47.9% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q4 2024 13F
Filed Feb 14, 2025
|
0 | $0 |
|
Q3 2024 13F
Filed Nov 14, 2024
|
68 | $2.0B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
61 | $1.9B |
|
Q1 2024 13F
Filed May 15, 2024
|
59 | $2.0B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
52 | $2.0B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
73 | $1.9B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
79 | $2.2B |
|
Q1 2023 13F
Filed May 15, 2023
|
75 | $2.0B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
71 | $1.9B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
73 | $1.8B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
76 | $1.6B |
|
Q1 2022 13F
Filed May 16, 2022
|
74 | $1.9B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
70 | $2.6B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
87 | $2.9B |
|
Q2 2021 13F
Filed Aug 16, 2021
|
95 | $2.8B |
|
Q1 2021 13F
Filed May 17, 2021
|
85 | $2.9B |
|
Q4 2020 13F
Filed Feb 16, 2021
|
78 | $3.1B |
|
Q3 2020 13F
Filed Nov 16, 2020
|
75 | $2.9B |
|
Q2 2020 13F
Filed Aug 14, 2020
|
65 | $2.3B |
|
Q1 2020 13F
Filed May 15, 2020
|
61 | $1.5B |
17 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MRTX Mirati Therapeutics Inc. | $164.4M | 8.45% |
| 2 | SWTX Springworks Therapeutics Inc | $117.2M | 6.02% |
| 3 | ITOS iTeos Therapeutics Inc | $102.7M | 5.28% |
| 4 | ONC BeiGene Ltd | $94.3M | 4.85% |
| 5 | RVMD Revolution Medicines Inc | $88.9M | 4.57% |
| 6 | RLAY Relay Therapeutics Inc | $79.9M | 4.11% |
| 7 | CYTK Cytokinetics Inc | $77.3M | 3.97% |
| 8 | PMVP PMV Pharmaceuticals Inc | $72.8M | 3.74% |
| 9 | TYRA Tyra Biosciences Inc | $69.0M | 3.55% |
| 10 | APLS Apellis Pharmaceuticals Inc | $66.2M | 3.4% |
| 11 | RXDX Prometheus Biosciences Inc | $64.7M | 3.33% |
| 12 | XBI SPDR SER TR | $62.9M | 3.23% |
| 13 | TNGX Tango Therapeutics Inc | $52.1M | 2.68% |
| 14 | MRUS Merus NV | $50.2M | 2.58% |
| 15 | RCUS Arcus Biosciences Inc | $45.2M | 2.32% |
| 16 | RETA Reata Pharmaceuticals Inc | $40.6M | 2.09% |
| 17 | SAGE Sage Therapeutics Inc | $36.2M | 1.86% |
| 18 | BPMC Blueprint Medicines Corp | $32.4M | 1.67% |
| 19 | IOVA Iovance Biotherapeutics Inc | $32.2M | 1.66% |
| 20 | ANAB AnaptysBio Inc | $32.2M | 1.65% |
Values as reported on the Q1 2022 Form 13F. Every position is in the holdings table below.